Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
STARD3
REST API REST API
Homo sapiens
STARD3 is differentially expressed in 27 experiments: 6 organism parts: adrenal gland, heart, ... (4 more);, 4 disease states: acute lymphoblastic leukemia, clinically isolated syndrome, ... (2 more);, 8 cell types 27 cell lines 2 compound treatments and 17 other conditions.
Synonyms MLN64, es64
Orthologs Stard3 (Mus musculus)   STARD3 (Gallus gallus)   E9PTK5_RAT (Rattus norvegicus)   STARD3 (Bos taurus)   stard3 (Danio rerio)   ENSCING00000006033 (Ciona intestinalis)   Start1 (Drosophila melanogaster)   stard3 (Xenopus laevis)   STARD3 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term lipid transport, steroid metabolic process, transport, cholesterol transporter activity, cytoplasm, membrane, lipid binding, cholesterol metabolic process, cholesterol binding, steroid biosynthetic process, lipid metabolic process, mitochondrial transport, endosome, integral to membrane, late endosome membrane
InterPro Term StAR, START_lipid-bd, MENTAL
UniProt Accession C9J555, A8MXA4, Q14849, B3KVT4, F5H0G2
Search EB-eye ENSG00000131748
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-96

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-19466, E-GEOD-21750, E-TABM-321, E-GEOD-29119, E-GEOD-19480, ... (6 experiments)

Factor Value U/D Experiments
NA19147
1
E-GEOD-19480
GM19193
1
E-GEOD-19466
NA18504
1
E-GEOD-19480
GM02783
1
E-TABM-321
NA19102
1
E-GEOD-19480
HMEC
1
E-GEOD-29119
21 more value(s).


Cell type

studied in E-GEOD-21909, E-GEOD-21750, E-GEOD-29119, E-GEOD-16190

Factor Value U/D Experiments
primary human mammary epithelial cells
1
E-GEOD-29119
CD4+ T cell
1
1
E-GEOD-16190
Monocytes
1
E-GEOD-21909
mesothelial cells
1
E-GEOD-21750
breast cancer
1
1
E-GEOD-29119
T cell
2
1
E-GEOD-16190
2 more value(s).


Disease state

studied in E-GEOD-14895, E-GEOD-96

Factor Value U/D Experiments
multiple sclerosis free
1
E-GEOD-14895
clinically isolated syndrome
1
E-GEOD-14895
acute lymphoblastic leukemia
1
E-GEOD-96
prior to onset of multiple sclerosis
1
E-GEOD-14895


Compound treatment

studied in E-GEOD-2292, E-GEOD-6462

Factor Value U/D Experiments
none
17
1
E-GEOD-2292
epidermal growth factor
1
1
E-GEOD-6462


Biopsy tissue

studied in E-GEOD-5851

Factor Value U/D Experiments
lung
1
E-GEOD-5851


BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19480

Clinical history
studied in E-GEOD-22097

Developmental stage
studied in E-GEOD-3140

Disease staging
studied in E-TABM-147

Genotype
studied in E-MEXP-1996, E-GEOD-2292, E-TABM-321, E-GEOD-1153

Growth condition
studied in E-TABM-263, E-MEXP-1220

Individual
studied in E-MTAB-197

organ
studied in E-GEOD-24283

Phenotype
studied in E-GEOD-21750

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-22097, E-GEOD-21837

Replicate
studied in E-GEOD-10797

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-GEOD-3697

sampleID
studied in E-GEOD-24283

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Processing time: 0.719 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM